NewslettersCancer Stem Cell NewsOrganoid NewsInhibition of DCLK1 Sensitizes Resistant Lung Adenocarcinomas to EGFR-TKI through Suppression of Wnt/β-Catenin Activity and Cancer StemnessBy Justin.choi - February 17, 2022073The authors investigated the role of the tumor stem cell marker DCLK1 in epithelial growth factor receptor-tyrosine kinase inhibitor resistance of lung adenocarcinoma.[Cancer Letters] 6445212 BBBBBBBB items 1 apa 0 default asc 1 172020 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article